Low-Concentration Atropine Eyedrops for Myopia in Children.

JAMA

Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan.

Published: June 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2023.7286DOI Listing

Publication Analysis

Top Keywords

low-concentration atropine
4
atropine eyedrops
4
eyedrops myopia
4
myopia children
4
low-concentration
1
eyedrops
1
myopia
1
children
1

Similar Publications

Therapeutic Efficacy of Highly Aspherical Lenslets Combined with Low-Concentration Atropine: A Retrospective Study.

Photodiagnosis Photodyn Ther

August 2025

Strabismus and Pediatric Ophthalmology, Shenzhen Eye Hospital, Shenzhen Eye Center, Southern Medical University, 518040, China. Electronic address:

Objective: The aim of this study is to evaluate the efficacy of 0.01% atropine (AT), highly aspherical lenslets (HAL), and their combination in controlling myopia progression in children and adolescents.

Methods: A retrospective cohort study was conducted involving 144 children and adolescents aged 8 to 15 years who visited Shenzhen Eye Hospital between 2022 and 2024.

View Article and Find Full Text PDF

Background: Childhood myopia has become a global public health problem and is growing rapidly in incidence, especially in East Asia. This study examined the prevention and control of myopia in children by systematically evaluating the interaction between genetic factors and visual behaviors to optimize prevention strategies.

Methods: Relevant articles were screened from PubMed and Web of Science.

View Article and Find Full Text PDF

0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia.

Sci Rep

August 2025

Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child dev

Myopia is the most widespread refractive error caused by an increase in the axial length (AL) of the eyeball, and is also a major risk factor for other blinding eye diseases, seriously endangering human health and quality of life. Investigating practical methods to control the progression of myopia is therefore crucial. The only medication that has been shown to effectively delay the progression of myopia over an extended period of time is atropine.

View Article and Find Full Text PDF

Purpose: To investigate the changes in the ocular surface and meibomian glands following the administration of 0.01 and 0.02% atropine.

View Article and Find Full Text PDF